These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18036969)

  • 1. Decreasing the expression of LFA-1 and ICAM-1 as well as hindering their interaction as the major mechanism for statin-induced neutrophil dysfunction.
    Namazi MR
    Ann Thorac Surg; 2007 Dec; 84(6):2137-8. PubMed ID: 18036969
    [No Abstract]   [Full Text] [Related]  

  • 2. Regarding "A novel molecular mechanism to account for the action of simvastatin against limb ischemia".
    Namazi H
    J Vasc Surg; 2008 Jun; 47(6):1378; author reply 1378. PubMed ID: 18514858
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells.
    Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Nishibori M
    Clin Immunol; 2005 Sep; 116(3):211-6. PubMed ID: 15936988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.
    Ullrich T; Baumann K; Welzenbach K; Schmutz S; Camenisch G; Meingassner JG; Weitz-Schmidt G
    Bioorg Med Chem Lett; 2004 May; 14(10):2483-7. PubMed ID: 15109637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.
    Giguère JF; Tremblay MJ
    J Virol; 2004 Nov; 78(21):12062-5. PubMed ID: 15479847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ICAM-1 and LFA-1 in hyperleukocytic acute myeloid leukaemia.
    Zhang W; Zhang X; Fan X; Li D; Qiao Z
    Clin Lab Haematol; 2006 Jun; 28(3):177-82. PubMed ID: 16706934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiinflammatory effects of statins.
    McCarey DW; McInnes IB; Sattar N
    N Engl J Med; 2001 Oct; 345(16):1209-10; author reply 1210-1. PubMed ID: 11642240
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreasing the expression of LFA-1 and ICAM-1 as the major mechanism for the protective effect of glutamine on ischemia-reperfusion injury.
    Acta Orthop; 2008 Apr; 79(2):308. PubMed ID: 18484261
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?
    Maher BM; Dhonnchu TN; Burke JP; Soo A; Wood AE; Watson RW
    J Leukoc Biol; 2009 Jan; 85(1):186-93. PubMed ID: 18840670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase.
    Rydgren T; Sandler S
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1076-9. PubMed ID: 19150339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles played by lymphocyte function-associated antigen-1 in the regulation of lymphocytic cholinergic activity.
    Fujii T; Takada-Takatori Y; Kawashima K
    Life Sci; 2007 May; 80(24-25):2320-4. PubMed ID: 17289088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
    Liang YJ; Shyu KG; Wang BW; Lai LP
    Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study.
    Guasti L; Marino F; Cosentino M; Cimpanelli M; Maio RC; Klersy C; Crespi C; Restelli D; Simoni C; Franzetti I; Gaudio G; Marnini P; Grandi AM; Lecchini S; Venco A
    J Hypertens; 2006 Dec; 24(12):2423-30. PubMed ID: 17082725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte function-associated antigen-1 blockade by statins: molecular basis and biological relevance.
    Weitz-Schmidt G
    Endothelium; 2003; 10(1):43-7. PubMed ID: 12699076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin abrogates inflamed neutrophil adhesive properties, in association with the inhibition of Mac-1 integrin expression and modulation of Rho kinase activity.
    Silveira AA; Dominical VM; Lazarini M; Costa FF; Conran N
    Inflamm Res; 2013 Feb; 62(2):127-32. PubMed ID: 23250325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing the expression of LFA-1 and ICAM-1 as the major mechanism for the protective effect of hyperbaric oxygen on ischemia-reperfusion injury.
    Namazi H
    Microsurgery; 2008; 28(4):300. PubMed ID: 18383352
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study.
    Ozeç I
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):605-6. PubMed ID: 19426916
    [No Abstract]   [Full Text] [Related]  

  • 18. Another reason to take your statin.
    Harv Heart Lett; 2001 Feb; 11(6):6-7. PubMed ID: 11175446
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation.
    Raemer PC; Kohl K; Watzl C
    Eur J Immunol; 2009 Jun; 39(6):1456-65. PubMed ID: 19424968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
    Kagami S; Kanari H; Suto A; Fujiwara M; Ikeda K; Hirose K; Watanabe N; Iwamoto I; Nakajima H
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():61-6. PubMed ID: 18504409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.